← Evidence map

ArticleJournal of cachexia, sarcopenia and muscle2022

Extracellular lipidome change by an SGLT2 inhibitor, luseogliflozin, contributes to prevent skeletal muscle atrophy in db/db mice.

Ryo Bamba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

42 papers cite it

2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34854254